Stay updated with breaking news from Launch Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Address the Sixty-second assemblies at in Geneva Photo Credit: IT Service Support Division Wednesday: October 6, 2021: The Minister...